Yohimbine Energy & Fat Loss By Prime Nutrition Precision Series Overview & Drug Interactions

Check For Interactions With Yohimbine Energy & Fat Loss

Supplement: Yohimbine Energy & Fat Loss by Prime Nutrition Precision Series

Yohimbine Energy & Fat Loss Label Images

This product contains

Below is a list of the 'active' ingredients listed on the supplement label for this product.

For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.

Drugs that interact with Yohimbine Energy & Fat Loss by Prime Nutrition Precision Series

Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.

There were no interactions found with Yohimbine Energy & Fat Loss. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about Yohimbine Energy & Fat Loss interactions? Ask Dr. Brian Staiger about it by contacting him directly.

Label Information

Supplement Facts:

Daily Value (DV) Target Group(s): Adults and children 4 or more years of age
Minimum serving Sizes:
1 Capsule(s)
Maximum serving Sizes:
1 Capsule(s)
Servings per container 90
UPC/BARCODE 689466706185

Ingredient Amount per Serving Group % DV, Adults & children 4+ years
Yohimbine HCl
2.5 mg
Yohimbine --

Other Ingredients:
Dicalcium Phosphate
Magnesium Stearate


Label Statments:


General Statements
- -THE BEST OR NOTHING-
- YOHIMBINE Yohimbine can be used to support fat loss and energy production. Yohimbine is for users aiming to improve lean body composition, suppress appetite, support sexual health and overall well-being.
- SUPPRESS APPETITE* MAXIMIZE SEX-DRIVE* SUPPORT FAT LOSS*
- WWW.PRIME NUTRITION.COM
- 90 SERVINGS & CAPSULES
Suggested/Recommended/Usage/Directions
- PERFORMANCE TRAINING USAGE: As a dietary supplement consume 1 capsule prior to a meal two times per day. Assess tolerance with one capsule. Do not exceed recommended daily dosage.
Formula
- 100% PURE Yohimbine HCL Capsules
Precautions
- WARNING: Not for use for individuals under the age of 18 years.
- Do not use if you are pregnant or nursing.
- Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Discontinue use and call a physician or licensed qualified health care professional immediately if you experience any adverse symptoms. Improper use of this product may be hazardous to a person's health. Exceeding recommended serving will not improve results.
FDA Disclaimer Statement
- * These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Formulation
- No Artificial Colors or Dyes
FDA Statement of Identity
- DIETARY SUPPLEMENT
Seals/Symbols
- P

Brand Information

See all products by this brand

Manufactured Exclusively For
Name Prime Nutrition(R) Prime Nutrition LLC
Street Address 21218 St. Andrews Blvd. Suite 230
City Boca Raton
State FL
ZipCode 33434
Distribution Inquiries
Email [email protected]

Return to the main supplement interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.